Protumor effects of proinflammatory mediators in breast cancer (original) (raw)

The Chemokine CXCL16 and Its Receptor, CXCR6, as Markers and Promoters of Inflammation-Associated Cancers

Merav Darash-yahana

PLoS ONE, 2009

View PDFchevron_right

The chemokine receptors CXCR4 and CXCR3 in cancer

Amy Fulton

Current oncology reports, 2009

View PDFchevron_right

The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines

Eran Neumark

Immunology Letters, 2004

View PDFchevron_right

CXCR4 and cancer

ahmed mohamed

Pathology International, 2010

View PDFchevron_right

Immunohistochemical Expression of CXCR4 on Breast Cancer and Its Clinical Significance

Carlos Eduardo Coral Oliveira

Analytical Cellular Pathology, 2015

View PDFchevron_right

Mini-review The role of CXC chemokines and their receptors in cancer

Itzel Camacho Blue

View PDFchevron_right

CXCR4 and cancer: CXCR4 and cancer

Ahmed Marouf

Pathology International, 2010

View PDFchevron_right

The Role of the CXCL12/CXCR4/ CXCR7 Chemokine Axis in Cancer

David Riese

Frontiers in Pharmacology, 2020

View PDFchevron_right

CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression

Russell Taichman

Cancer and Metastasis Reviews, 2010

View PDFchevron_right

CXC chemokines located in the 4q21 region are up-regulated in breast cancer

Carine Chavey, Gwendal Lazennec

Endocrine Related Cancer, 2007

View PDFchevron_right

Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity

Nathan Karin

Cytokine, 2018

View PDFchevron_right

Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients

Tim Bartels

British Journal of Cancer, 2008

View PDFchevron_right

Multiple functions of CXCL12 in a syngeneic model of breast cancer

Mark Smyth

Molecular Cancer, 2010

View PDFchevron_right

CXCL4 and CXCL4L1 in cancer

Pieter Ruytinx

Cytokine, 2018

View PDFchevron_right

The role of CXC chemokine ligand 4/CXC chemokine receptor 3-B in breast cancer progression

Roland Osei Saahene

Biotechnic & Histochemistry, 2018

View PDFchevron_right

Scientific heading: Chemokines PF4/CXCL4 and CXCL4L1 exhibit distinct subcellular localization and a differentially regulated mechanism of secretion

laura lasagni

2007

View PDFchevron_right

Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases

Ahmed Merzouk

View PDFchevron_right

The Chemokine CXCL8 in Carcinogenesis and Drug Response

Temesgen Samuel

ISRN Oncology, 2013

View PDFchevron_right

Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4

Mario Mellado

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2017

View PDFchevron_right

Expression of the inflammatory chemokines CCL2, CCL5 and CXCL2 and the receptors CCR1–3 and CXCR2 in T lymphocytes from mammary tumor-bearing mice

Michael Criscitiello, Marta Torroella-Kouri

Cellular Immunology, 2011

View PDFchevron_right

Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands

Gary Luker

Oncogene, 2010

View PDFchevron_right

Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12

Rakesh Arya

2012

View PDFchevron_right

Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells

Hamid Band

Oncogene, 2004

View PDFchevron_right

The chemokine CXCL14 (BRAK) stimulates activated NK cell migration: Implications for the downregulation of CXCL14 in malignancy

Richard Dahl

Experimental Hematology, 2006

View PDFchevron_right

CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity

Mario Mellado

Immunity, 2020

View PDFchevron_right

The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis

Russell Taichman

Cancer and Metastasis Reviews, 2007

View PDFchevron_right